QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer

Conditions:   Thyroid Cancer;   Colon Cancer;   Ovarian Cancer;   Breast Cancer;   Lung Cancer;   Pancreatic Cancer
Interventions:   Biological: ETBX-011;   Biological: ALT-803
Sponsor:   NantCell, Inc.
Not yet recruiting - verified April 2017

http://ift.tt/2qbh6wy